Home > Healthcare > Biotechnology > Biotechnology R&D > Transfection Technologies Market

Transfection Technologies Market Size

  • Report ID: GMI9113
  • Published Date: Jul 2024
  • Report Format: PDF

Transfection Technologies Market Size

Transfection Technologies Market size was valued at around USD 1.2 billion in 2023 and is estimated to grow at 8.9% CAGR from 2024 to 2032. Transfection technologies encompass a diverse array of methodologies employed in molecular biology and biotechnology to introduce exogenous nucleic acids, such as DNA, RNA, or oligonucleotides, into living cells.

 

The primary goal of transfection is to manipulate gene expression, study gene function, or develop therapeutic strategies by delivering genetic material into target cells. This process is fundamental to various research fields including genetic engineering, gene therapy, and drug discovery. The increasing prevalence of chronic diseases includes cardiovascular diseases, diabetes, and cancer serves as a substantial impetus for market growth. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. Thus, the advancement and widespread adoption of transfection technologies are essential for enhancing the diagnosis, treatment management, and risk prediction of cancer.

 

Furthermore, rise in research and development in the field of cell-based therapies, technological advancement, and expanded applications of transfection technologies, are the contributing factors stimulating the growth of the market.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Transfection technologies market size was worth USD 1.2 billion in 2023 and will grow at an 8.2% CAGR between 2024 and 2032, fueled by integral role in genetic testing, biotechnology, and pharmaceutical development

The kits and reagents segment recorded USD 828.5 million in 2023 led by the surge in product launches by major players

North America transfection technologies industry size will record USD 1.1 billion by 2032, owing to substantial investments in biotechnology and pharmaceutical research

Some of the leading transfection technologies industry players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Lonza, MaxCyte, Inc., QIAGEN N.V., and Revvity, Inc. among others.

Transfection Technologies Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 312
  • Countries covered: 22
  • Pages: 201
 Download Free Sample